The Microbiome Diagnostics Market on a global scale was estimated at USD 154.9 Mn in 2023 and is expected to attain USD 488.2 Mn by 2031, with a projected CAGR of 15.6% between 2024 and 2031.
Microbiome Diagnostics encompasses challenges.
Several factors contribute to this trajectory, including heightened requirement next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region expected to deliver the strongest growth trajectory through the forecast period, driven by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Microbiome Diagnostics Market Snapshot
Chapter 4. Global Microbiome Diagnostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:
5.2.1. Reagents & Kits
5.2.2. Instruments
Chapter 6. Market Segmentation 2: by Technology Estimates & Trend Analysis
6.1. by Technology & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Technology:
6.2.1. 16S rRNA Sequencing
6.2.2. Shot Gun Metagenomics
6.2.3. Metatranscriptomics
6.2.4. Other Technology
Chapter 7. Market Segmentation 3: by Sample Estimates & Trend Analysis
7.1. by Sample & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Sample:
7.2.1. Feces
7.2.2. Saliva
7.2.3. Skin
7.2.4. Other Sample
Chapter 8. Market Segmentation 4: by Application Estimates & Trend Analysis
8.1. by Application & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
8.2.1. Disease Diagnostics Application
8.2.1.1. Gastrointestinal Disorders
8.2.1.2. Metabolic Diseases
8.2.1.3. Other Application
8.2.2. Research Application
Chapter 9. Market Segmentation 5: by End-user Estimates & Trend Analysis
9.1. by End-user & Market Share, 2019 & 2031
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-user:
9.2.1. Hospitals
9.2.2. Academic and Research Institutes
9.2.3. Biotechnology and Pharmaceutical Companies
Chapter 10. Microbiome Diagnostics Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Microbiome Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2019-2031
10.1.2. North America Microbiome Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2019-2031
10.1.3. North America Microbiome Diagnostics Market revenue (US$ Million) by Sample, 2019-2031
10.1.4. North America Microbiome Diagnostics Market revenue (US$ Million) by Application, 2019-2031
10.1.5. North America Microbiome Diagnostics Market revenue (US$ Million) by End-user, 2019-2031
10.1.6. North America Microbiome Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.2. Europe
10.2.1. Europe Microbiome Diagnostics Market revenue (US$ Million) by Product Type, 2019-2031
10.2.2. Europe Microbiome Diagnostics Market revenue (US$ Million) by Technology, 2019-2031
10.2.3. Europe Microbiome Diagnostics Market revenue (US$ Million) by Sample, 2019-2031
10.2.4. Europe Microbiome Diagnostics Market revenue (US$ Million) by Application, 2019-2031
10.2.5. Europe Microbiome Diagnostics Market revenue (US$ Million) by End-user, 2019-2031
10.2.6. Europe Microbiome Diagnostics Market revenue (US$ Million) by country, 2019-2031
10.3. Asia Pacific
10.3.1. Asia Pacific Microbiome Diagnostics Market revenue (US$ Million) by Product Type, 2019-2031
10.3.2. Asia Pacific Microbiome Diagnostics Market revenue (US$ Million) by Technology, 2019-2031
10.3.3. Asia-Pacific Microbiome Diagnostics Market revenue (US$ Million) by Sample, 2019-2031
10.3.4. Asia Pacific Microbiome Diagnostics Market revenue (US$ Million) by Application, 2019-2031
10.3.5. Asia Pacific Microbiome Diagnostics Market revenue (US$ Million) by End-user, 2019-2031
10.3.6. Asia Pacific Microbiome Diagnostics Market revenue (US$ Million) by country, 2019-2031
10.4. Latin America
10.4.1. Latin America Microbiome Diagnostics Market revenue (US$ Million) by Product Type, 2019-2031
10.4.2. Latin America Microbiome Diagnostics Market revenue (US$ Million) by Technology, 2019-2031
10.4.3. Latin America Microbiome Diagnostics Market revenue (US$ Million) by Sample, 2019-2031
10.4.4. Latin America Microbiome Diagnostics Market revenue (US$ Million) by Application, 2019-2031
10.4.5. Latin America Microbiome Diagnostics Market revenue (US$ Million) by End-user, 2019-2031
10.4.6. Latin America Microbiome Diagnostics Market revenue (US$ Million) by country, 2019-2031
10.5. Middle East & Africa
10.5.1. Middle East & Africa Microbiome Diagnostics Market revenue (US$ Million) by Product Type, 2019-2031
10.5.2. Middle East & Africa Microbiome Diagnostics Market revenue (US$ Million) by Technology, 2019-2031
10.5.3. Middle East & Africa Microbiome Diagnostics Market revenue (US$ Million) by Sample, 2019-2031
10.5.4. Middle East & Africa Microbiome Diagnostics Market revenue (US$ Million) by Application, 2019-2031
10.5.5. Middle East & Africa Microbiome Diagnostics Market revenue (US$ Million) by End-user, 2019-2031
10.5.6. Middle East & Africa Microbiome Diagnostics Market revenue (US$ Million) by country, 2019-2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Yakult Honsha Co.
11.2.2. AOBiome
11.2.3. Enterome Biosciences SA
11.2.4. Metabiomics Corp. (BioSpherex LLC)
11.2.5. Microbiome Therapeutics LLC
11.2.6. Osel, Inc.
11.2.7. Rebiotix, Inc.
11.2.8. Second Genome
11.2.9. Seres Therapeutics
11.2.10. Synthetic Biologics, Inc.
11.2.11. Vedanta Biosciences
11.2.12. 4D Pharma
11.2.13. Du Pont De Nemours and Co.
11.2.14. Ferring Pharmaceuticals
11.2.15. Genetic Analysis AS
11.2.16. Atlas Biomed
11.2.17. Biome Oxford Ltd.
11.2.18. Illumina Inc.
11.2.19. Microba Life Sciences
11.2.20. Dna Genotek (Orasure Technologies, Inc.)
11.2.21. Viome Life Sciences
11.2.22. Sun Genomics
11.2.23. Becton, Dickinson And Company
11.2.24. Daytwo
11.2.25. OraSure Technologies, Inc.
11.2.26. Other Prominent Players